Neurogene
NGNE
$18.51
Share price
-2.57%
Change (1 day)
-71.94%
Change (1 year)
Neurogene (NGNE) - Cash on Hand
Cash on Hand as of September 2024 : S$0.18 Billion
According to Neurogene's latest financial reports the company has S$0.18 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Neurogene - Cash on Hand chart (from 2023 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | S$0.26 B | 136.81% |
| 2022-12-31 | S$0.10 B | 15.3% |
| 2021-12-31 | S$95.36 M |